Advertisement
Screener

Minerva Neurosciences, Inc. (NERV) Notes Payable, Current

2.8 / 5 stars · 68/120 Roast Me

Minerva Neurosciences, Inc. Notes Payable, Current

Minerva Neurosciences, Inc. (NERV) had Notes Payable, Current of $1.40 million as of 2018-06-30, per its 10-Q filed 2018-08-02.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current

us-gaap:NotesPayableCurrent · last filed 2019-03-12

  • 2018-06-30: Notes Payable, Current $1.40M.
  • 2018-03-31: Notes Payable, Current $2.70M.
  • 2017-12-31: Notes Payable, Current $3.96M.
  • 2017-09-30: Notes Payable, Current $5.19M.
Period endNotes Payable, Current
2018-06-30$1.40M
10-Q · filed 2018-08-02
2018-03-31$2.70M
10-Q · filed 2018-05-03
2017-12-31$3.96M
10-K · filed 2019-03-12
2017-09-30$5.19M
10-Q · filed 2017-11-06
2017-06-30$5.07M
10-Q · filed 2017-08-03
2017-03-31$4.96M
10-Q · filed 2017-05-04
2016-12-31$4.85M
10-K · filed 2018-03-12
2016-09-30$4.75M
10-Q · filed 2016-11-03
2016-06-30$3.88M
10-Q · filed 2016-08-04
2016-03-31$2.64M
10-Q · filed 2016-05-03
2015-12-31$1.43M
10-K · filed 2017-03-13
2015-09-30$251.59K
10-Q · filed 2015-11-05
2015-06-30$1.09M
10-Q · filed 2015-08-05
2015-03-31$158.26K
10-Q · filed 2015-05-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Annexon, Inc. (ANNX)United States$0.147B-4.22
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91